This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IPC The Hospitalist Company Reports 2013 Second Quarter Results

NORTH HOLLYWOOD, Calif., July 25, 2013 (GLOBE NEWSWIRE) -- IPC The Hospitalist Company, Inc. (Nasdaq:IPCM), a leading national hospitalist physician group practice, today announced financial results for the second quarter ended June 30, 2013. All operating results referred to as "adjusted" exclude the change in fair market value of contingent consideration ("net change in fair value"). See "Reconciliation of Non-GAAP Financial Measures" below for explanations of these non-GAAP financial measures and reconciliation to GAAP financial measures.

Second Quarter 2013 Highlights (comparisons are to second quarter 2012):

  • Net revenue increased 14% to $145.8 million.  
  • Patient encounters increased to 1,513,000, a 13% increase.  
  • Adjusted income from operations increased 13% to $14.8 million. GAAP income from operations increased 59% to $20.0 million.  
  • Adjusted net income increased 12% to $9.1 million, or $0.53 adjusted diluted earnings per share. GAAP net income increased 57% to $12.3 million, or $0.71 diluted earnings per share.

Six Months Ended June 30, 2013 Highlights (comparisons are to six months ended June 30, 2012):

  • Net revenue increased 16% to $298.8 million.  
  • Patient encounters increased to an all-time high of 3,089,000, a 14% increase.  
  • Adjusted income from operations increased 15% to $30.8 million. GAAP income from operations increased 41% to $37.2 million.  
  • Adjusted net income increased 13% to $18.9 million, or $1.10 adjusted diluted earnings per share. GAAP net income increased 40% to $22.8 million, or $1.33 diluted earnings per share.

Adam D. Singer, M.D., Chief Executive Officer of IPC The Hospitalist Company, stated, "Our continued double digit growth in patient encounters, revenues and adjusted operating income affirms the long-term viability of the IPC model, which offers physicians an environment to focus on patient care and improved patient outcomes. We are confident in our ability to execute on our proven growth strategies in both our acute and post-acute lines of business."

1 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs